Skip to main content
Eric Huselton, MD, Hematology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

EricJohnHuseltonMD

Hematology Rochester, NY

Hematologic Oncology

Assistant Professor, Leukemia/Blood and Marrow Transplant Program

Dr. Huselton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huselton's full profile

Already have an account?

Summary

  • Dr. Eric Huselton is a hematologist in Rochester, NY and is affiliated with Strong Memorial Hospital of the University of Rochester. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 5 years. He specializes in hematologic oncology and is experienced in hematologic oncology, leukemia, and stem cell transplant.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2012

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2025
  • MO State Medical License
    MO State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
    Eric Huselton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDSClinically Relevant Abst... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • CX-01, an inhibitor of CXCL12/CXCR4 axis and of platelet factor 4 (PF4), with azacitidine (AZA) in patients with hypomethylating agent (HMA) refractory AML and MDS. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Suny Downstate Internal Medicine Residency
    Suny Downstate Internal Medicine ResidencyDecember 24th, 2020
  • Suny Downstate Hematology Oncology Fellowship
    Suny Downstate Hematology Oncology FellowshipJune 11th, 2021
  • Suny Downstate Hematology Oncology Fellowship
    Suny Downstate Hematology Oncology FellowshipJune 8th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations